Friday,
June 13 |
| INVEST in patients with CAD and hypertension | |
| Sponsored by Abbott | |
| Chairmen: G. Mancia (Monza, Italy) C. Pepine (Gainesville, FL, USA) > Welcome,
symposia objectives > Rationale,
design and unique characteristics of the INVEST trial > Baseline
results of the INVEST > Primary
endpoints of INVEST > INVEST
results in context vs. other key trials > INVEST
moving forward > Panel discussion > Closing remarks |
|
| For information contact: Mrs. Eleonora Pasqualini AISC & MGR - AIM Group Via A. Ristori, 38 - 00197 Rome (Italy) Tel. +39-0680968304 - Fax. +39.0680968229 E-Mail: e.pasqualini@aisc.it |